Edmonton, AB – March 13, 2017 –Radient Technologies (“Radient” or the “Company”) (TSX-V: RTI) today expressed its support for the industry-leading product testing disclosure initiative of its joint research partner, Aurora Cannabis Inc. ("Aurora") (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM).

On March 9, Aurora introduced the cannabis sector’s most comprehensive product testing disclosure process, providing its clients and the general public with access to a simplified Certificate of Analysis (CoA) for every cannabis product available for sale on the Aurora's menu. Subsequent to Aurora’s initiative, similar guidelines and standards were announced by Cannabis Canada Association, the leading organization for Health Canada Licensed Producers of cannabis.

The full article can be accessed here.